HomeCompareMNA vs JNJ

MNA vs JNJ: Dividend Comparison 2026

MNA yields 1.04% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MNA wins by $1.1K in total portfolio value
10 years
MNA
MNA
● Live price
1.04%
Share price
$36.31
Annual div
$0.38
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$111.25
Full MNA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MNA vs JNJ

📍 MNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNA
Annual income on $10K today (after 15% tax)
$88.39/yr
After 10yr DRIP, annual income (after tax)
$94.56/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $609.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNA + JNJ for your $10,000?

MNA: 50%JNJ: 50%
100% JNJ50/50100% MNA
Portfolio after 10yr
$20.6K
Annual income
$469.51/yr
Blended yield
2.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MNA
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNA buys
0
JNJ buys
0
No recent congressional trades found for MNA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNAJNJ
Forward yield1.04%3.36%
Annual dividend / share$0.38$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.2K$20.0K
Annual income after 10y$111.25$827.78
Total dividends collected$1.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MNA vs JNJ ($10,000, DRIP)

YearMNA PortfolioMNA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,804$103.99$10,676$355.77+$128.00MNA
2$11,665$105.00$11,407$389.39+$258.00MNA
3$12,588$105.95$12,198$426.53+$390.00MNA
4$13,576$106.85$13,056$467.62+$520.00MNA
5$14,634$107.70$13,987$513.12+$647.00MNA
6$15,767$108.50$14,998$563.56+$769.00MNA
7$16,980$109.25$16,098$619.52+$882.00MNA
8$18,278$109.95$17,295$681.69+$983.00MNA
9$19,668$110.62$18,599$750.82+$1.1KMNA
10$21,156$111.25$20,022$827.78+$1.1KMNA

MNA vs JNJ: Complete Analysis 2026

MNAStock

The NYLI Merger Arbitrage ETF (MNA) seeks investment results that track, before fees and expenses, the price and yield performance of the NYLI Merger Arbitrage Index. The Index seeks to achieve capital appreciation by investing in global companies for which there has been a public announcement of a takeover by an acquirer. This differentiated approach is based on a passive strategy of owning certain announced takeover targets, with the goal of generating returns that are representative of global merger arbitrage activity. In addition, for transactions that involve an exchange of stock, the Index includes short exposure to the stock expected to be received by shareholders of the target company.

Full MNA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MNA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNA vs SCHDMNA vs JEPIMNA vs OMNA vs KOMNA vs MAINMNA vs ABBVMNA vs MRKMNA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.